Novozymes A/S
Novozymes A/S (NVZMF) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
nvzmf · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Hold
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $56.36
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $55.83 | ↓ 0.94% |
1-day model range: $55.5–$56.15. Peak: $56.15 (-0.94%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $60 | +6.6% |
| 2028 | $63 | +11.1% |
| 2029 | $64 | +14.2% |
| 2030 | $66 | +16.2% |
| 2031 | — | +17.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · NVZMF · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2019-03-26 | JP Morgan | Downgrade ↓ | Neutral→Underweight |
| 2015-08-06 | Jefferies | Maintains | Hold→Hold |
Wall Street analysts have recently issued updated ratings on Novozymes A/S (NVZMF) stock. Of the recent 2 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover NVZMF.
Analyst Recommendation Trends
NVZMF analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$33.4B
↓ 13.1% YoY
Revenue Next Year
$35.8B
↑ 7.3% YoY
EPS This Year
$15.20
EPS Next Year
$16.84
↑ 10.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast NVZMF EPS of $15.20 for the current fiscal year, based on estimates from 4 analysts. The NVZMF revenue forecast is $33.4B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The NVZMF stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NVZMF price target is $0.00 (+0.0% upside), with an analyst consensus of Hold.
The NVZMF short-term stock prediction for tomorrow is $55.83 (-0.94%). The NVZMF stock price prediction for 2027 estimates an average of $60. The NVZMF stock prediction for 2030 projects a range of $61–$70.
Novozymes A/S trades on OTC under the ticker NVZMF. The NVZMF stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.
Frequently asked questions
NVZMF forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month NVZMF price target is $0.00, with a high forecast of $0.00 and a low of $0.00. The median price target is shown in the chart above when available. This implies +0.0% potential upside from the current price of $56.36.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.